- Home
- IVP vs BJDX Comparison
IVP vs BJDX Comparison
Compare IVP & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- BJDX
- Stock Information
- Founded
- IVP 2020
- BJDX 2015
- Country
- IVP United States
- BJDX United States
- Employees
- IVP N/A
- BJDX N/A
- Industry
- IVP Diversified Commercial Services
- BJDX Medical Specialities
- Sector
- IVP Miscellaneous
- BJDX Health Care
- Exchange
- IVP Nasdaq
- BJDX Nasdaq
- Market Cap
- IVP 3.3M
- BJDX 2.9M
- IPO Year
- IVP 2023
- BJDX 2021
- Fundamental
- Price
- IVP $1.66
- BJDX $1.58
- Analyst Decision
- IVP
- BJDX
- Analyst Count
- IVP 0
- BJDX 0
- Target Price
- IVP N/A
- BJDX N/A
- AVG Volume (30 Days)
- IVP 76.0K
- BJDX 2.1M
- Earning Date
- IVP 08-13-2025
- BJDX 08-13-2025
- Dividend Yield
- IVP N/A
- BJDX N/A
- EPS Growth
- IVP N/A
- BJDX N/A
- EPS
- IVP N/A
- BJDX N/A
- Revenue
- IVP $15,399,751.00
- BJDX N/A
- Revenue This Year
- IVP N/A
- BJDX N/A
- Revenue Next Year
- IVP N/A
- BJDX $55.56
- P/E Ratio
- IVP N/A
- BJDX N/A
- Revenue Growth
- IVP N/A
- BJDX N/A
- 52 Week Low
- IVP $1.26
- BJDX $1.46
- 52 Week High
- IVP $401.50
- BJDX $44.50
- Technical
- Relative Strength Index (RSI)
- IVP 46.82
- BJDX 42.16
- Support Level
- IVP $1.51
- BJDX $1.49
- Resistance Level
- IVP $1.76
- BJDX $1.63
- Average True Range (ATR)
- IVP 0.13
- BJDX 0.16
- MACD
- IVP -0.02
- BJDX -0.00
- Stochastic Oscillator
- IVP 18.43
- BJDX 7.29
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.